|
|
||||||||
|
FIGURE 3. Time course of 18F-FDG PET in a nonresponder patient (patient 1). (A) Intense 18F-FDG uptake in baseline study clearly depicts irregular tumor mass. (B) Tumor uptake is roughly unchanged in intermediate study (early SUV change, 15%). (C) In presurgical study, tumor volume is reduced but considerable tumor uptake is still present (late SUV change, 23%). This case was graded TRG4.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |